<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00279604</url>
  </required_header>
  <id_info>
    <org_study_id>01EB0432</org_study_id>
    <nct_id>NCT00279604</nct_id>
  </id_info>
  <brief_title>INCA - Intervention and Neuropsychology in Cannabis Abuse</brief_title>
  <official_title>Targeted Interventions in Cannabis Abuse: Focus on Decision Making (INCA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <brief_summary>
    <textblock>
      INCA (Intervention and Neuropsychology of Cannabis Abuse) is a study combining two research&#xD;
      goals. One is to study efficacy of a short intervention the 'Problem Profile Intervention',&#xD;
      which utilizes individual feedback from a 'substance problem check-up'. Subjects will&#xD;
      randomly receive the 'Problem Profile Intervention' or the WHO Brief Intervention, a brief&#xD;
      intervention, which has been shown to be efficacious. Currently efficiency studies are under&#xD;
      way. The WHO Brief Intervention has been translated into German by our group. In contrast to&#xD;
      most other cannabis intervention studies the current study is focussed on cannabis abusers&#xD;
      not so much cannabis-dependent subjects. A total of 160 subjects are to be recruited. Half of&#xD;
      them will randomly receive either the Problem Profile Intervention or the WHO Brief&#xD;
      Intervention (active control). A total of 25% of subjects from each group will be placed on a&#xD;
      3 months waiting list before receiving the intervention (inactive control). Intervention&#xD;
      outcome will be assessed three months, six month and 12 months after the intervention. We&#xD;
      hypothesize cannabis use to be reduced by 25% by the 'Problem Profile Intervention'. The&#xD;
      second aim of the study is to study mechanism of substance abuse. Initial results from own&#xD;
      studies and data from other groups point to executive cognitive functions as a subtle but&#xD;
      important factor that can be compromised in cannabis users (Verdejo-Garcia et al., 2004;&#xD;
      Garavan and Stout, 2005). Using an fMRI-study, we intend to examine a subgroup of our&#xD;
      subjects on a specific aspect of executive functioning that has recently received major&#xD;
      interest in drug research: Decision-making capability, or risk-taking behaviour, respectively&#xD;
      (e.g. Ernst and Paulus, 2005).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2005</start_date>
  <completion_date type="Anticipated">October 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cannabis consumption,</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>motivational change</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>ASSIST-Score</measure>
  </secondary_outcome>
  <enrollment>160</enrollment>
  <condition>Marijuana Abuse</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>'Problem Profile Intervention' vs. WHO-Brief Intervention</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASSIST-Score for cannabis consume ≥ 4 ≤ 26&#xD;
&#xD;
          -  german mother tongue (or comparable level)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  major current psychiatric disorder (e.g. psychosis)&#xD;
&#xD;
          -  addiction to other illegal drugs or alcohol&#xD;
&#xD;
          -  recent or current intravenous drug use&#xD;
&#xD;
          -  CNS-affecting medication&#xD;
&#xD;
          -  current psychotherapy, other treatment for substance use disorder&#xD;
&#xD;
        exclusion criteria for fMRI-part:&#xD;
&#xD;
          -  left-handedness&#xD;
&#xD;
          -  medication (birth control pill, thyroid gland hormones possible)&#xD;
&#xD;
          -  internistic illnesses (hypertension, diabetes, diseases of lungs)&#xD;
&#xD;
          -  metallic implants (cardiac pacemaker, ferromagnetic object implanted through surgical&#xD;
             intervention or accident, large-area tattoos)&#xD;
&#xD;
          -  history of serious trauma&#xD;
&#xD;
          -  claustrophobia&#xD;
&#xD;
          -  gestation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian G Schuetz, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bonn, Department of Psychiatry</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian G Schuetz, MD MPH</last_name>
    <phone>+49 228 287 9664</phone>
    <email>christian.schütz@ukb.uni-bonn.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Friedrich-Wilhelms-University, Department of Psychiatry</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian G Schütz, MD MPH</last_name>
      <phone>+49 228 2879664</phone>
      <email>christian.schütz@ukb.uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Christian G Schütz, MD MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Essen, Department of Psychiatry and Psychotherapy</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Scherbaum, MD</last_name>
      <phone>+49 201 7227 180</phone>
      <email>norbert.scherbaum@uni-essen.de</email>
    </contact>
    <investigator>
      <last_name>Norbert Scherbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <study_first_submitted>January 18, 2006</study_first_submitted>
  <study_first_submitted_qc>January 18, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2006</study_first_posted>
  <last_update_submitted>April 19, 2007</last_update_submitted>
  <last_update_submitted_qc>April 19, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

